Enabling the Advancement of Molecular Medicine
The lack of early detection and actionability costs the healthcare industry over a trillion dollars each year. Molecular You (MY) is leading the rising research and development by providing a comprehensive multi-omic analysis that potentially provide accurate, predictive insights into health risks, biological pathways at the root cause of the risk at the earliest phase of pathogenesis to enable safe, effective and personalized interventions.
The platform is a two sided solution that employs advanced artificial intelligence (AI) tools and scientific expertise to:
a) select high value metabolites and proteins with the supporting documentation and wet lab validation to be incorporated into our multiplexed LC/MS/MS quantitation assays, and
b) interpret the data and potentially provide health insights in an easy to use, practical interface that removes the friction for adopting molecular medicine.
This multi-omic chipset and software pairing is regularly reassessed and updated. It is also designed to incorporate other Omic assay data in collaboration with clinical research labs. MY technologies are particularly useful for measuring a wide range of interconnected molecular, microbial, and physiological changes, including those driven by pharmaceutical interventions.
Having demonstrated MY can also support the selection and development of safe and effective therapies in collaboration with pharmaceutical companies. The expanding database of longitudinal multi-omic and EHR data is designed to be analysed by researchers to generate new knowledge into the mechanisms of health and disease towards the establishment of more effective therapeutic interventions.
Presenter: Rob Fraser (CSO and President, Co-Founder, Molecular You Corporation)
Rob was the founding CEO and is the current President and CSO of Molecular You Corporation. Backed by his expertise in molecular diagnostics, molecularly targeted drug discovery and development, biochemistry and regulatory compliance, Rob Fraser drives the innovation behind Molecular You’s multi-biomarker analytics. He established a low cost method of measuring hundreds of biomarkers from a single blood sample, along with establishing a LLM model to incorporate the world’s leading scientific literature.
Rob has also been involved in leading drug discovery and development projects at Sanofi, Xenon, Neuromed and CDRD. Rob received extensive training in the molecular mechanisms of endocrinology while completing his Ph.D. at the University of Alberta and Harvard Medical School and Post-Doctoral Fellowships at Hospital for Sick Children, Toronto and IGBMC, Strasbourg, France. In addition to Rob’s scientific accomplishments, he has been involved in the raising of more than $37M in funding. Rob is also co-founder of GenXys Health Care Systems, Personalized Biomarkers Incorporated, Mesentech Corporation and Novobind.
